Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Actavis Group's US subsidiary Actavis has rolled out Levetiracetam Extended-Release Tablets to treat partial-onset seizures in patients with epilepsy.
Subscribe to our email newsletter
Levetiracetam Extended-Release Tablets are the generic version of Keppra XR of UCB.
Keppra is an anti-epileptic drug which is indicated for the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.
Actavis is engaged in the development, manufacture and sale of generic pharmaceuticals.